<p>Dr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer.&nbsp;</p><p>CME information and select publications <a href="https://www.researchtopractice.com/AUA2025/AKTiProstate" rel="noopener noreferrer" target="_blank">here</a>. </p>

Prostate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.